Lal PathLabs can fortify its hold if suburban is integrated well
Synopsis
Dr Lal PathLabs (LPL), India’s largest diagnostics player by revenue and presence, is slated to become bigger with the acquisition of Suburban Diagnostics, which has a sizable presence in western India. At the total deal value of Rs 1,150 crore, LPL valued Sequoia Capital-backed Suburban at nearly four times its FY21 revenue.
ET Intelligence Group: Dr Lal PathLabs (LPL), India’s largest diagnostics player by revenue and presence, is slated to become bigger with the acquisition of Suburban Diagnostics, which has a sizable presence in western India. At the total deal value of Rs 1,150 crore, LPL valued Sequoia Capital-backed Suburban at nearly four times its FY21 revenue.
The acquisition is going to provide LPL scale and penetration – it will help it add 44
- FONT SIZE
AbcSmall
AbcMedium
AbcLarge
Sign in to read the full article
You’ve got this Prime Story as a Free Gift
₹399/month
Monthly
PLAN
Billed Amount ₹399
₹208/month
(Save 49%)
Yearly
PLAN
Billed Amount ₹2,499
15
Days Trial
+Includes DocuBay and TimesPrime Membership.
₹150/month
(Save 63%)
2-Year
PLAN
Billed Amount ₹3,599
15
Days Trial
+Includes DocuBay and TimesPrime Membership.
Already a Member? Sign In now
Get Offer
Why ?
-
Exclusive Economic Times Stories, Editorials & Expert opinion across 20+ sectors
-
Stock analysis. Market Research. Industry Trends on 4000+ Stocks
-
Clean experience with
Minimal Ads -
Comment & Engage with ET Prime community -
Exclusive invites to Virtual Events with Industry Leaders -
A trusted team of Journalists & Analysts who can best filter signal from noise
For all the latest Business News Click Here
For the latest news and updates, follow us on Google News.